Jiangzhong Pharmaceutical Co Ltd (600750) — Financial Flexibility Index
Jiangzhong Pharmaceutical Co Ltd (600750) has a Financial Flexibility Index of 0.03x as of December 2025. Free cash flow of CN¥74.16 Million (operating CF CN¥-2.91 Million minus capex CN¥77.07 Million) represents 0% of total liabilities (CN¥2.18 Billion). Check Jiangzhong Pharmaceutical Co Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Jiangzhong Pharmaceutical Co Ltd Financial Flexibility Index (1998–2025)
Historical Financial Flexibility Index trend for Jiangzhong Pharmaceutical Co Ltd across 28 annual periods. For the full cash flow conversion analysis, see Jiangzhong Pharmaceutical Co Ltd (600750) cash flow conversion.
Annual Financial Flexibility Index for Jiangzhong Pharmaceutical Co Ltd (1998–2025)
Year-by-year free cash flow to debt coverage for Jiangzhong Pharmaceutical Co Ltd. Explore cash flow to debt ratio of Jiangzhong Pharmaceutical Co Ltd to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.57x | CN¥1.25 Billion | CN¥970.87 Million | CN¥2.18 Billion | ▲ +8.6% |
| 2024 | 0.53x | CN¥1.08 Billion | CN¥786.25 Million | CN¥2.04 Billion | ▼ -24.7% |
| 2023 | 0.70x | CN¥1.24 Billion | CN¥1.04 Billion | CN¥1.77 Billion | ▼ -9.2% |
| 2022 | 0.77x | CN¥1.37 Billion | CN¥1.02 Billion | CN¥1.77 Billion | ▼ -1.0% |
| 2021 | 0.78x | CN¥1.11 Billion | CN¥917.04 Million | CN¥1.42 Billion | ▼ -43.8% |
| 2020 | 1.39x | CN¥935.04 Million | CN¥752.50 Million | CN¥672.27 Million | ▲ +61.8% |
| 2019 | 0.86x | CN¥717.51 Million | CN¥641.18 Million | CN¥834.84 Million | ▼ -20.3% |
| 2018 | 1.08x | CN¥607.62 Million | CN¥486.25 Million | CN¥563.53 Million | ▲ +58.0% |
| 2017 | 0.68x | CN¥306.14 Million | CN¥124.93 Million | CN¥448.74 Million | ▼ -60.0% |
| 2016 | 1.71x | CN¥768.11 Million | CN¥698.05 Million | CN¥449.96 Million | ▼ -3.6% |
| 2015 | 1.77x | CN¥573.53 Million | CN¥510.78 Million | CN¥323.74 Million | ▲ +360.7% |
| 2014 | 0.38x | CN¥459.14 Million | CN¥356.80 Million | CN¥1.19 Billion | ▲ +87.2% |
| 2013 | 0.21x | CN¥176.51 Million | CN¥111.92 Million | CN¥859.15 Million | ▼ -46.4% |
| 2012 | 0.38x | CN¥450.80 Million | CN¥226.38 Million | CN¥1.18 Billion | ▼ -38.1% |
| 2011 | 0.62x | CN¥415.84 Million | CN¥168.30 Million | CN¥671.11 Million | ▲ +24.0% |
| 2010 | 0.50x | CN¥363.16 Million | CN¥222.29 Million | CN¥726.93 Million | ▼ -34.1% |
| 2009 | 0.76x | CN¥397.68 Million | CN¥378.32 Million | CN¥524.73 Million | ▲ +61.5% |
| 2008 | 0.47x | CN¥289.37 Million | CN¥268.87 Million | CN¥616.73 Million | ▲ +9.3% |
| 2007 | 0.43x | CN¥164.79 Million | CN¥153.63 Million | CN¥383.89 Million | ▲ +184.7% |
| 2006 | 0.15x | CN¥85.94 Million | CN¥55.24 Million | CN¥569.95 Million | ▼ -74.3% |
| 2005 | 0.59x | CN¥263.87 Million | CN¥198.45 Million | CN¥449.20 Million | ▲ +1.9% |
| 2004 | 0.58x | CN¥289.31 Million | CN¥26.28 Million | CN¥501.74 Million | ▼ -35.5% |
| 2003 | 0.89x | CN¥310.40 Million | CN¥78.98 Million | CN¥347.14 Million | ▼ -29.6% |
| 2002 | 1.27x | CN¥210.31 Million | CN¥94.90 Million | CN¥165.58 Million | ▲ +141.8% |
| 2001 | 0.53x | CN¥46.34 Million | CN¥41.28 Million | CN¥88.23 Million | ▼ -42.6% |
| 2000 | 0.92x | CN¥148.99 Million | CN¥121.77 Million | CN¥162.71 Million | ▲ +938.5% |
| 1999 | -0.11x | CN¥-17.63 Million | CN¥-21.89 Million | CN¥161.46 Million | ▼ -356.9% |
| 1998 | 0.04x | CN¥6.10 Million | CN¥-11.42 Million | CN¥143.42 Million | — |